期刊文献+

鼻咽癌患者唾液和血清及外周血白细胞中EBV-DNA的定量检测 被引量:3

Quantitative analysis of Epstein-Barr virus DNA in saliva,blood serum and peripheral blood cells in patients with nasopharyngeal carcinoma
暂未订购
导出
摘要 目的对鼻咽癌患者唾液、血清及外周血白细胞中的EBV-DNA进行检测,分析唾液、血清、外周血白细胞中EB病毒的DNA含量与鼻咽癌的相关性。方法对40例初诊鼻咽癌患者和50例正常人的唾液、血清及外周血白细胞中的EBV-DNA进行荧光聚合酶链反应(FQ-PCR)检测。结果EBV-DNA在鼻咽癌患者血清中的检出率为67.5%,显著高于正常人血清中的EBV-DNA检出率2%(χ2=44.48,P<0.001);鼻咽癌患者的唾液、外周血白细胞EBV-DNA检出率与正常人相比,无显著性差异;鼻咽癌患者和正常人的唾液EBV-DNA拷贝数与外周血白细胞EBV-DNA拷贝数呈正相关性;鼻咽癌患者血清EBV-DNA拷贝数与TNM分级有关,分级越晚含量越高。结论 EB病毒长期存在于多数人的唾液中,也可存在于外周血B淋巴细胞中。血清EBV-DNA检测在鼻咽癌的临床诊断中具有较高的敏感性和特异性,有助于鼻咽癌的早期诊断;血清EBV-DNA拷贝数与TNM分级有关,可在分子水平对鼻咽癌的TNM分级进行补充。 To quantitatively analyze DNA levels of Epstein Barr virus (EBV) in saliva, blood serum, and peripheral blood cells ( PBCs ) of nasopharyngeal carcinoma ( NPC ) patients, and to investigate the relationship between EBVDNA levels and NPC. Methods EBVDNA levels in samples of saliva, blood serum and PBCs from 40 primary NPC patients and 50 controls were quantitatively detected with real-time quantitative PCR (FQ-PCR) respectively. Results The detective rate of EBVDNA in blood serum from NPCs (67. 5 % ) was significantly higher than that in the controls 2% ( X2 = 44. 48, P 〈 0. 001 ). The differences of EBVDNA detective rates in the saliva, PBCs between the NPCs and control group were statistically insignificant. Saliva EBVDNA level was correlated with PBCs EBV-DNA load in both NPCs and the control. In NPC patients, blood serum EBVDNA level was significantly increasing with the advance in TNM stage. Conclusion Epstein Barr virus may exist in saliva and peripheral blood B lymphocyte in most normal people. With high sensitivity and specificity, the blood serum EBV-DNA examination may be helpful in the early diagnosis of NPC, and also facilitate the TNM stagingof NPC in clinical practice.
出处 《中国耳鼻咽喉颅底外科杂志》 CAS 2012年第1期24-27,共4页 Chinese Journal of Otorhinolaryngology-skull Base Surgery
关键词 鼻咽癌 EB病毒脱氧核糖核酸 血清 唾液 外周血白细胞 Nasopharyngeal neoplasm EBVDNA Saliva Blood serum Peripheral blood cell
  • 相关文献

参考文献15

二级参考文献55

  • 1刘泰福,徐国镇.全国鼻咽癌会议纪要[J].中华放射肿瘤学杂志,1992,0(4):5-10. 被引量:132
  • 2卢泰祥,赵充,吴少雄,罗伟,陈勇,谢方云,陈明,曾祥发,胡伟汉,曹新平,夏云飞,刘秀芳,崔念基.鼻咽癌单纯常规外照射放疗疗效的分析[J].中华肿瘤杂志,2005,27(10):620-622. 被引量:90
  • 3赵充,卢泰祥,韩非,卢丽霞,黄劭敏,邓小武,林承光,崔念基.139例鼻咽癌调强放疗的临床研究[J].中华放射肿瘤学杂志,2006,15(1):1-6. 被引量:155
  • 4[2]Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cellfree Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma[J]. Cancer Res, 1999, 59(6):1188~1191
  • 5[3]Anker P, Mulcahy H, Chen XQ, et al. Detection of circulating tumor DNA in blood (plasma/serum) of cancer patients[J]. Cancer Metastasis Rev, 1999, 18(1): 65~73
  • 6[4]Mutirangura A, Pomthanakasem W, Theamboonlers A, et al.Epstein-Barr viral DNA in serum of patients in nasopharyngeal carcinoma[J]. Clin Cancer Res, 1998, 4(3): 665~669
  • 7[5]Shotelesuk K, Khorprasert C, Sakdikul S, et al. Epstein-Bart viral DNA in serum/plasma as a tumor marker for nasopharyngeal carcinoma[J]. Clin Cancer Res, 2000, 6(3): 1046~1051
  • 8[6]Lo YM, Leung SF, Chan LY, et al. Kinetics of plasma EpsteinBarr virus DNA during radiation therapy for nasopharyngeal carcinoma[J]. Cancer Res, 2000, 60(9): 2351~2355
  • 9[8]Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Bart virus DNA [J]. Cancer Res, 2000, 60 (24): 6878~6881
  • 10[9]Chant AT, Lo YM, Zee B, et al. Plasma Epstein-Bart virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma [J]. J Natl Cancer Inst, 2002, 94 (21):1614~1619

共引文献105

同被引文献41

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部